<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20200429</date><key>pmc.key</key><document><id>6011374</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.1186/s12884-018-1887-x</infon><infon key="article-id_pmc">6011374</infon><infon key="article-id_pmid">29925344</infon><infon key="article-id_publisher-id">1887</infon><infon key="elocation-id">251</infon><infon key="kwd">Vitamin D Pregnancy Pregnancy outcome Gestational diabetes mellitus Fetal sex</infon><infon key="license">Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</infon><infon key="name_0">surname:Wilson;given-names:Rebecca L.</infon><infon key="name_1">surname:Leviton;given-names:Alison J.</infon><infon key="name_10">surname:Roberts;given-names:Claire T.</infon><infon key="name_11">surname:Anderson;given-names:Paul H.</infon><infon key="name_12">surname:Grzeskowiak;given-names:Luke E.</infon><infon key="name_13">surname:McCowan;given-names:Lesley</infon><infon key="name_2">surname:Leemaqz;given-names:Shalem Y.</infon><infon key="name_3">surname:Anderson;given-names:Paul H.</infon><infon key="name_4">surname:Grieger;given-names:Jessica A.</infon><infon key="name_5">surname:Grzeskowiak;given-names:Luke E.</infon><infon key="name_6">surname:Verburg;given-names:Petra E.</infon><infon key="name_7">surname:McCowan;given-names:Lesley</infon><infon key="name_8">surname:Dekker;given-names:Gustaaf A.</infon><infon key="name_9">surname:Bianco-Miotto;given-names:Tina</infon><infon key="section_type">TITLE</infon><infon key="title">Keywords</infon><infon key="type">front</infon><infon key="volume">18</infon><infon key="year">2018</infon><offset>0</offset><text>Vitamin D levels in an Australian and New Zealand cohort and the association with pregnancy outcome</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>100</offset><text>Background</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>111</offset><text>Pregnant women are at increased susceptibility to vitamin D deficiency. Hence, there is continuing interest in determining how vitamin D influences pregnancy health. We aimed to compare vitamin D status in two distinct populations of pregnant women in Australia and New Zealand and to investigate the relationship between vitamin D status and pregnancy outcome. This included evaluating possible effect measure modifications according to fetal sex.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>560</offset><text>Methods</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>568</offset><text>Serum 25-hydroxy vitamin D (25(OH)D) was measured at 15âÂ±â1Â weeksâ gestation in 2800 women from Adelaide and Auckland who participated in the multi-centre, prospective cohort SCreening fOr Pregnancy Endpoints (SCOPE) study.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>800</offset><text>Results</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>808</offset><text>Mean serum 25(OH)D in all women was 68.1âÂ±â27.1Â nmol/L and 28% (nâ=â772) were considered vitamin D deficient (&lt;â50Â nmol/L). Serum 25(OH)D was lower in the women recruited in Adelaide when compared to the women recruited in Auckland and remained lower after adjusting for covariates including maternal body mass index and socioeconomic index (Adelaide: 58.4âÂ±â50.3 vs. Auckland: 70.2âÂ±â54.5Â nmol/L, Pâ&lt;â0.001). A 53% decreased risk for gestational diabetes mellitus (GDM) was observed with high (&gt;â81Â nmol/L) âstandardisedâ vitamin D status when compared to moderate-high (63â81Â nmol/L, aRR, 0.47; 95% CI: 0.23, 0.96). Marginal sex-specific differences occurred between vitamin D status and GDM: women carrying a female fetus had a 56% decreased risk for GDM in those with low-moderate levels of standardised vitamin D (44â63Â nmol/L) compared to moderate-high levels (aRR: 0.44; 95% CI: 0.20, 0.97), whilst in women carrying a male fetus, a 55% decreased risk of GDM was found with high standardised vitamin D when compared to moderately-high vitamin D, but this was not statistically significant (aRR: 0.45; 95% CI: 0.15, 1.38).</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1978</offset><text>Conclusions</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1990</offset><text>High serum 25(OH)D at 15âÂ±â1Â weeksâ gestation was shown to be protective against the development of GDM. A possible association between fetal sex, vitamin D status and GDM provides further questions and encourages continual research and discussion into the role of vitamin D in pregnancy, particularly in vitamin D replete populations.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>2334</offset><text>Electronic supplementary material</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>2368</offset><text>The online version of this article (10.1186/s12884-018-1887-x) contains supplementary material, which is available to authorized users.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2504</offset><text>Background</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2515</offset><text>With an increasing prevalence of vitamin D deficiency and insufficiency reported both in Australia and New Zealand, as well as worldwide, there is continuing interest in determining how vitamin D deficiency may influence health in pregnancy. Evidence suggests that vitamin D deficiency is associated with a number of pregnancy complications including preeclampsia (PE), gestational diabetes mellitus (GDM) and spontaneous preterm birth (sPTB). However, inconsistencies between studies reflect uncertainty about the true effect of vitamin D deficiency on pregnancy outcome. This may be explained, in part, by inadequate control of related risk factors and confounders in statistical analyses, variations between assays that measure vitamin D and significant heterogeneity between studied populations.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3315</offset><text>Vitamin D status is determined by measuring circulating serum levels of 25-hydroxy vitamin D2â+â3 (25(OH)D). In Australia and New Zealand, the deficiency cut-offs are based on the role of vitamin D in bone health where serum 25(OH)Dââ¥â50Â nmol/L at the end of winter is required for optimal musculoskeletal health. Furthermore, it has been established that serum 25(OH)Dââ¥â50Â nmol/L is recommended during pregnancy and lactation. The incidence of vitamin D deficiency (Ë50Â nmol/L) is frequent among pregnant women even in areas such as Australia and the North Island of New Zealand where sunlight exposure is high. Studies focused on high-risk populations, for example, veiled, dark-skinned or obese women in Australia and New Zealand, report between 50 and 94% of women to be vitamin D deficient. Reports from lower-risk groups have indicated that vitamin D deficiency occurs in 25â55% of pregnant women.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4242</offset><text>There are numerous studies which have shown that vitamin D deficiency is associated with adverse pregnancy outcomes (Most recent:), particularly in populations that reside at higher latitudes. However, studies in women from Australia and New Zealand are less consistent. Previous studies on pregnant Australian and New Zealand women have reported that while circulating 25(OH)D was significantly lower in women with PE, sPTB, GDM and those who delivered a small-for gestational age (SGA) infant, no association between vitamin D deficiency and these pregnancy complications was found after adjusting for covariates. Differences in ethnicity, solar exposure and geographical location, as well as genetics and supplementation, are known to affect 25(OH)D status and therefore influence study outcomes. Furthermore, the gestation at which vitamin D was measured is also important. In the case of preterm delivery, vitamin D status measured closer to the delivery date was more significantly associated with preterm delivery than earlier measures. However, measuring circulating 25(OH)D in early pregnancy is common and potentially clinically useful as this is prior to when many of the pregnancy complications that affect late gestation manifest.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5486</offset><text>Using a robust, validated chemiluminescent-based assay to measure serum 25(OH)D, we aimed to investigate the differences between vitamin D status in early pregnancy in two distinct populations of nulliparous women from Australia and New Zealand. We also aimed to examine the relationship between serum 25(OH)D at 15âÂ±â1Â weeksâ gestation and the risk of an adverse pregnancy outcome and included determining the effect modification of fetal sex on the association between maternal vitamin D status and pregnancy outcome.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>6014</offset><text>Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6022</offset><text>Study population</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6039</offset><text>This study utilised data collected from the multi-centre, prospective cohort Screening for Pregnancy Endpoints (SCOPE) study. Nulliparous women carrying a singleton pregnancy were recruited between November 2004 and September 2008 in Adelaide (Australia) and Auckland (New Zealand). Ethics approval was obtained from Central Northern Adelaide Health Service Ethics of Human Research Committee on 2 September 2005 (ethics number REC 1714/5/2008) and Northern Region Ethics Committee, in Auckland on 23 April 2003 (ethics number AKX/02/00/364). All participants provided written informed consent. At 15âÂ±â1Â weeksâ gestation, women were interviewed by a research midwife and asked questions on maternal demographics and lifestyle and had physical measurements taken, including height and weight. Records included ethnicity, age, body mass index (BMI), socioeconomic index (SEI) and multivitamin use. BMI was calculated as weight (kg)/height2 (m2). Obesity was defined as BMI â¥30Â kg/m2, overweight as BMI â¥25 andâ&lt;â30Â kg/m2, normal weight as BMI &gt;â20 andâ&lt;â25Â kg/m2 and underweight as BMI â¤20Â kg/m2. SEI was calculated using the New Zealand SEI of occupational status, deriving a number between 10 and 90 based on the womanâs occupation; a higher number indicates higher socioeconomic status. This population of women was predominantly Caucasian and thus maternal ethnicity was categorised into 2 main groups; Caucasian and non-Caucasian. Uncomplicated pregnancies were defined as those without any pregnancy disorder who delivered an appropriate weight for gestational age infant at term (â¥37Â weeks gestation). Pregnancy complications studied included PE, gestational hypertension (GH), GDM, sPTB and SGA and have been previously defined.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7808</offset><text>Measurement of serum 25(OH)D</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7837</offset><text>Non-fasting whole peripheral blood samples were collected into non-heparinised tubes at 15Â±1 weeksâ gestation. Serum was processed within 4Â h of collection and stored at ââ80Â Â°C until required. Unlike the previously published data on vitamin D in the Auckland cohort, serum 25(OH)D was measured using the IDS-iSYS chemiluminescent-based assay (Abacus, ALS) as per the manufacturerâs instructions. Average intra- and inter-assay coefficient of variation (CV) were 5.4 and 8.8%, respectively. Both serum 25(OH)D3 and 25(OH)D2 were measured independently and combined to provide a total 25(OH)D in nmol/L.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>8452</offset><text>Statistical analyses</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8473</offset><text>Statistical analyses were performed in R (v3.1.1). Data were checked for normality using a Shapiro-Wilks test and differences between women recruited in Adelaide compared to Auckland were tabulated and compared using a Welchâs t-test (continuous variables) or Fisherâs exact test (categorical variables).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8782</offset><text>Given that the month in which the serum was sampled heavily influences vitamin D status, âstandardisedâ serum 25(OH)D concentrations were calculated as previously described in order to normalise against seasonal variation. Briefly, vitamin D concentrations were standardized by taking the difference of 25(OH)D concentration to the average 25(OH)D concentration of the corresponding month. This 25(OH)D concentration was then added to the overall population mean 25(OH)D concentration: 68.09Â nmol/L. Quartiles, based on the distribution amongst the population of women studied, in the standardised concentrations were then used to create cut-points and designated âlowâ (&lt;â44Â nmol/L), âlow-moderateâ (44â63Â nmol/L), âmoderate-highâ (63â81Â nmol/L) and âhighâ (&gt;â81Â nmol/L) categories of serum 25(OH)D.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9616</offset><text>Generalised linear models (Poisson with log link and robust variance estimates) were used to calculate the risk ratios for pregnancy complications by standardised serum 25(OH)D concentrations calculated among the women who had an uncomplicated pregnancy. Potential confounders for vitamin D status were assessed using linear modelling. Maternal age, BMI, SEI, alcohol consumption at 15âÂ±â1Â weeksâ gestation (never/former vs. current), recreational walking (1â3 times/week andââ¥â4 times/week vs. never), ethnicity (Caucasian vs. non-Caucasian) and recruitment site (Adelaide vs. Auckland) were significantly associated with serum 25(OH)D and along with smoking status at 15âÂ±â1Â weeksâ gestation (never/former vs. current) included as main effects within the generalised linear models. These analyses were also repeated but using the current definitions of vitamin D deficiency: &lt;â25, 25â50, 50â75 andâ&gt;â75Â nmol/L in the non-standardised data. We also stratified based on fetal sex to evaluate possible effect measure modifications according to whether the mother was carry a male or female fetus.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>10747</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>10755</offset><text>Population characteristics</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><offset>10782</offset><text>	All women (n = 2800)	Adelaide (n = 1156)	Auckland (n = 1644)	P value*
Age yrs, mean (SD)	28 (6)	23.73 (5.11)	30.44 (4.82)	&lt;0.0001
BMI kg/m2, mean (SD)	25.8 (5.44)	27.04 (6.56)	24.88 (4.26)	&lt;0.0001
Ethnicity				&lt;0.0001
âCaucasian	2449 (87)	1060 (92)	1389 (84)	
âNon Caucasian	351 (13)	96 (8)	255 (16)	
Smoking status, n (%)				&lt;0.0001
âNo	2152 (77)	704 (61)	1448 (88)	
âQuit during pregnancy	306 (11)	175 (15)	131 (8)	
âSmoking	342 (12)	277 (24)	65 (4)	
Alcohol Consumption, n (%)				&lt;0.0001
âNo	1480 (53)	708 (61)	772 (47)	
âStopped during pregnancy	1185 (42)	397 (34)	788 (48)	
âConsuming alcohol	135 (5)	51 (4)	84 (5)	
Fruit Intake, n (%)				&lt;0.0001
ââ¥1x per day	2032 (73)	586 (51)	1446 (88)	
â3-6x per week	405 (14)	272 (24)	133 (8)	
â1-2x per week	223 (8)	181 (16)	42 (3)	
â1-3x per month or less	140 (5)	117 (10)	23 (1)	
Recreational Walking				&lt;0.0001
âNever	428 (15)	265 (23)	163 (10)	
â1-3 times/week	1773 (63)	668 (58)	1105 (68)	
ââ¥4 times/week	590 (22)	221 (19)	369 (23)	
Time watching TV				&lt;0.0001
â&lt;5 hours per day	2404 (86)	901 (78)	1503 (92)	
ââ¥5 hours per day	387 (14)	253 (22)	134 (8)	
Season serum was sampled				0.3213
âSummer	636 (23)	278 (24)	358 (22)	
âAutumn	705 (25)	273 (24)	432 (26)	
âWinter	727 (26)	300 (26)	427 (26)	
âSpring	732 (26)	305 (26)	427 (26)	
Serum 25(OH)D nmol/L, mean (SD)	68.09 (27.14)	60.06 (23.68)	73.74 (27.99)	&lt;0.0001
Vitamin D Status				&lt;0.0001
â&lt;25 nmol/L	99 (4)	48 (4)	51 (3)	
â25-50 nmol/L	673 (24)	375 (32)	298 (18)	
â50-75 nmol/L	928 (33)	422 (37)	506 (31)	
â&gt;75 nmol/L	1098 (39)	311 (27)	787 (48)	
</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>12391</offset><text>Participant characteristics and comparison of characteristics between women recruited at the Adelaide and Auckland SCOPE centres</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>12520</offset><text>*P values for continuous variables were determined using a Welchâs t-test and categorical variables a Fisherâs exact test comparing Adelaide and Auckland women</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12684</offset><text>Of 3229 women recruited as part of SCOPE at the Adelaide and Auckland centres, serum samples at 15âÂ±â1Â weeksâ gestation to measure 25(OH)D were available for 2800 (87%) women of whom, 1156 (41%) were recruited in Adelaide and 1644 (59%) were recruited in Auckland. Maternal characteristics are shown in TableÂ 1. Compared to women who were recruited at the Adelaide site, women recruited in Auckland were older, had a lower BMI, less likely to smoke or drink alcohol during pregnancy and more likely to eat fruit and undertake recreational walks. MeanâÂ±âSD SEI of the Auckland women was also higher compared to that in women recruited in Adelaide (Auckland: 48.0âÂ±â14.8 vs. Adelaide: 27.7âÂ±â10.5, Pâ&lt;â0.001). Given that all these factors significantly influenced serum 25(OH)D in the linear regression model, it was unsurprising that vitamin D status of the women was significantly different between the two recruitment sites. However, after adjusting for maternal age, BMI, SEI, smoking status and alcohol consumption at 15âÂ±â1Â weeksâ gestation, ethnicity, recreational walking and season, the women recruited in Adelaide still had significantly lower serum 25(OH)D when compared with those in Auckland (Adelaide: 58.4âÂ±â50.3 vs. Auckland: 70.2âÂ±â54.5Â nmol/L, Pâ&lt;â0.001) indicating the influence of other confounders not measured as part of the study on vitamin D status.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>14107</offset><text>Standardising serum 25(OH)D based on seasonal variation</text></passage><passage><infon key="file">12884_2018_1887_Fig1_HTML.jpg</infon><infon key="id">Fig1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>14163</offset><text>Seasonal variation in serum 25(OH)D. a. Comparison of serum 25(OH)D levels based on month of sampling in the women recruited in Adelaide (black line &amp; left axis) and average hours of sunlight per day in Adelaide (grey line &amp; right axis). Seasonal variation in vitamin D followed a similar pattern to hours of sunlight although was slightly shifted. b. Seasonal variation of serum 25(OH)D based on month of sampling between women recruited in Adelaide compared to Auckland. Data are meanâÂ±âSD</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14660</offset><text>As expected, there was a seasonal influence on serum 25(OH)D and thus, âstandardisedâ vitamin D concentrations were calculated to account for the month of serum collection. Average hours of sunlight per day in Adelaide from September 2005 to September 2008 were obtained from the Australian Government Bureau of Meteorology and compared against serum vitamin D measured in the women recruited in Adelaide (Fig.Â 1a; black line/left axis serum 25(OH)D and grey line/right axis average hours of sunlight). The means for serum 25(OH)D by month of sampling were also separated for women recruited in Adelaide and women recruited in Auckland (Fig. 1b).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>15312</offset><text>Serum 25(OH)D and pregnancy outcome</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15348</offset><text>Of the 2800 women present in this study, 1217 (43%) women went on to develop a pregnancy complication and included 5.8% (nâ=â161) who developed PE, 7.6% (nâ=â213) who developed GH, 3.3% (nâ=â92) who developed GDM, 5% (nâ=â139) who spontaneously delivered preterm and 10.6% (nâ=â298) who delivered an SGA infant.</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><offset>15680</offset><text>		Pregnancy Complications
All women	Any Complication	PE	GH	GDM	sPTB	SGA
n (%)	n (%)	aRR*(95% CI)	n (%)	aRR*(95% CI)	n (%)	aRR*(95% CI)	n (%)	aRR*(95% CI)	n (%)	aRR*(95% CI)	n (%)	aRR*(95% CI)
Standardised Quartiles**													
âLow	711 (25)	328 (46)	0.95 (0.85, 1.07)	46 (6)	1.02 (0.66, 1.57))	57 (8)	0.97 (0.67, 1.42)	28 (4)	0.79 (0.47, 1.30)	36 (5)	0.83 (0.54, 1.29)	84 (12)	1.02 (0.75, 1.39)
âLow-Moderate	755 (27)	318 (42)	1.00 (0.90, 1.12)	42 (6)	1.07 (0.69, 1.64)	65 (9)	1.06 (0.74, 1.52)	25 (3)	0.67 (0.39, 1.16)	33 (4)	0.87 (0.56, 1.35	72 (10)	0.98 (0.73, 1.32)
âModerate-High	702 (25)	309 (44)	1.0â 	37 (5)	1.0â 	50 (7)	1.0â 	28 (4)	1.0â 	39 (6)	1.0â 	81 (12)	1.0â 
âHigh	630 (23)	258 (41)	0.93 (0.82, 1.06)â 	35 (6)	1.24 (0.78, 1.96)	40 (6)	0.87 (0.58, 1.30)	10 (2)	0.47(0.23, 0.96)	30 (5)	0.77 (0.48, 1.25)	60 (10)	0.80 (0.57, 1.11)
Vitamin D Status													
â&lt;25 nmol/L	99 (4)	51 (52)	1.10 (0.89, 1.36)	8 (8)	1.44 (0.68, 3.03))	6 (6)	0.70 (0.32, 1.52)	5 (5)	0.98 (0.38, 2.52)	7 (7)	1.44 (0.68, 3.04)	13 (13)	1.15 (0.66, 2.01)
â25-50 nmol/L	673 (24)	301 (45)	0.93 (0.83, 1.03)	45 (7)	1.18 (0.80, 1.75)	59 (9)	0.97 (0.71, 1.34)	26 (4)	0.89 (0.54, 1.47)	29 (4)	0.75 (0.48, 1.16)	74 (11)	0.93 (0.69, 1.24)
â&gt;50-75 nmol/L	928 (33)	428 (46)	1.0â 	48 (5)	1.0â 	80 (9)	1.0â 	35 (4)	1.0â 	52 (6)	1.0â 	107 (12)	1.0â 
â&gt;75 nmol/L	1098 (39)	435 (40)	0.95 (0.86, 1.04)	60 (5)	1.28 (0.87, 1.87)	67 (6)	0.82 (0.59, 1.12)â 	26 (2)	0.78 (0.48, 1.28)	51 (5)	0.86 (0.59, 1.26)	104 (9)	0.86 (0.67, 1.12)
</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>17215</offset><text>Adjusted relative risks (aRR) of pregnancy complications from any complication, preeclampsia (PE), gestational hypertension (GH), gestational diabetes mellitus (GDM), spontaneous preterm birth (sPTB) and small-for-gestational age (SGA) according to vitamin D status categorised based on standardised quartiles and clinical definitions of vitamin D status</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>17570</offset><text>*Relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non Caucasian vs. Caucasian), smoking status at 15âÂ±â1Â weeksâ gestation (no vs. yes), alcohol consumption at 15âÂ±â1Â weeksâ (no vs yes), recreational walking (1-3Ã/week andââ¥â4Ã/week vs. never) and recruitment site (Auckland vs. Adelaide)</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>17930</offset><text>**Serum 25(OH)D was standardised for month that serum was sampled based as previously described </text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>18027</offset><text>â Reference category</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18049</offset><text>The association between âstandardisedâ 25(OH)D with pregnancy complications is presented in TableÂ 2. Using moderate-high as a reference (standardised vitamin D 63â81Â nmol/L), there was no appreciable effect of having a low, low-moderate or high vitamin D with the risk of developing any pregnancy complication after adjusting for confounders. However, when each pregnancy complication was analysed separately, a 53% decreased risk for GDM was observed with high vitamin D status when compared to moderate-high status (aRR: 0.47; 95% CI: 0.23, 0.96). When women were categorised based on clinical definitions of vitamin D deficiency and serum 25(OH)D between 50 and 75Â nmol/L used as the reference, no significant relationship between vitamin D status and adverse pregnancy outcome was found (Table 2). Although, the point estimates indicated a marginal increased risk for developing any pregnancy complication with severe (&lt;â25Â nmol/L) vitamin D deficiency compared to those who had levels between 50 and 75Â nmol/L (aRR: 1.10; 95% CI: 0.89, 1.36).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>19110</offset><text>Serum 25(OH)D, pregnancy outcome and fetal sex</text></passage><passage><infon key="file">Tab3.xml</infon><infon key="id">Tab3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><offset>19157</offset><text>		Pregnancy Complications
All women	Any Complication	PE		GH		GDM		sPTB		SGA
n (%)	n (%)	aRR* (95% CI)	n (%)	aRR* (95% CI)	n (%)	aRR* (95% CI)	n (%)	aRR* (95% CI)	n (%)	aRR* (95% CI)	n (%)	aRR* (95% CI)
Standardised Quartiles**
Males
âLow	367 (26)	173 (47)	1.00 (0.85, 1.18)	24 (7)	1.24 (0.65, 2.34)	31 (8)	1.11 (0.64, 1.94)	18 (5)	1.25 (0.58, 2.68)	22 (6)	1.09 (0.60, 1.98)	43 (12)	1.14 (0.73, 1.79)
âLow-Moderate	364 (26)	163 (45)	1.01 (0.86, 1.19))	20 (5)	1.11 (0.58, 2.12)	32 (9)	1.25 (0.73, 2.13)	13 (4)	1.06 (0.48, 2.38)	18 (5)	0.93 (0.49, 1.76)	45 (12)	1.23 (0.80, 1.88)
âModerate-High	359 (25)	152 (42)	1.0â 	16 (4)	1.0â 	23 (6)	1.0â 	11 (3)	1.0â 	18 (5)	1.0â 	35 (10)	1.0â 
âHigh	325 (23)	111 (34)	0.86 (0.71, 1.04)	15 (5)	1.18 (0.59, 2.36)	17 (5)	0.90 (0.50, 1.62)	4 (1)	0.45 (0.15, 1.38)	15 (5)	0.97 (0.50, 1.88)	26 (8)	0.77 (0.47, 1.26)
Females
âLow	380 (28)	169 (44)	0.91 (0.77, 1.06)	23 (6)	0.85 (0.47, 1.55)	30 (8)	0.87 (0.52, 1.45)	13 (3)	0.51 (0.25, 1.04)	14 (4)	0.61 (0.31, 1.18)	45 (12)	0.88 (0.58, 1.35)
âLow-Moderate	353 (26)	168 (48)	0.99 (0.85, 1.15)	24 (7)	1.03 (0.57, 1.85)	31 (9)	0.92 (0.57, 1.50)	9 (3)	0.44(0.20, 0.97)	18 (5)	0.79 (0.43, 1.45)	33 (9)	0.74 (0.48, 1.13)
âModerate-High	334 (24)	149 (45)	1.0â 	19 (6)	1.0â 	28 (8)	1.0â 	17 (5)	1.0â 	21 (6)	1.0â 	31 (9)	1.0â 
âHigh	314 (23)	128 (41)	1.00 (0.84, 1.19)	19 (6)	1.29 (0.70, 2.35)	20 (6)	0.85 (0.49, 1.46)	6 (2)	0.48 (0.19, 1.23)	12 (4)	0.60 (0.30, 1.21)	29 (9)	0.82 (0.53, 1.28)
</text></passage><passage><infon key="file">Tab3.xml</infon><infon key="id">Tab3</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>20652</offset><text>Adjusted relative risks (aRR) of pregnancy complications from any complication, preeclampsia (PE), gestational hypertension (GH), gestational diabetes mellitus (GDM), spontaeous preterm birth (sPTB) and small-for-gestational age (SGA) according to vitamin D status and stratified by fetal sex</text></passage><passage><infon key="file">Tab3.xml</infon><infon key="id">Tab3</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>20945</offset><text>*Relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non Caucasian vs. Caucasian), smoking status at 15âÂ±â1Â weeksâ gestation (no vs. yes), alcohol consumption at 15âÂ±â1Â weeksâ (no vs yes), recreational walking (1-3Ã/week andââ¥â4Ã/week vs. never) and recruitment site (Auckland vs. Adelaide)</text></passage><passage><infon key="file">Tab3.xml</infon><infon key="id">Tab3</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>21305</offset><text>**Serum 25(OH)D was standardised for month that serum was sampled based as previously described </text></passage><passage><infon key="file">Tab3.xml</infon><infon key="id">Tab3</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>21402</offset><text>â Reference category</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>21424</offset><text>As there is evidence to suggest that vitamin D metabolism within the placenta may differ with respect to fetal sex thus, we assessed the effect of âstandardisedâ vitamin D status on pregnancy outcome stratified by fetal sex (TableÂ 3). Although not statistically significant, point estimates for women carrying a male fetus indicated decreased risk of having any pregnancy complication with high serum 25(OH)D compared to moderately-high (aRR: 0.86; 9%% CI: 0.71, 1.04). This was largely driven by a 55% decreased risk of GDM in women with a male fetus with high standardised serum 25(OH)D when compared to those carrying a male fetus with moderate-high serum 25(OH)D (aRR: 0.45; 95% CI: 0.15, 1.38). Conversely, if a woman was carrying a female fetus, there was generally no effect of having low, low-moderate or high standardised serum 25(OH)D on developing any pregnancy complication compared to moderate-high levels (Table 3). Although, a 56% decreased risk for GDM was observed in those with low-moderate levels of standardised vitamin D when compared to moderate-high levels for women carrying a female fetus (aRR: 0.44; 95% CI: 0.20, 0.97). Similar results were observed when vitamin D status was based on clinical definitions of deficiency (Additional file 1: Table S1).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>22707</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>22718</offset><text>This study adds to the current body of literature on vitamin D status in a population of pregnant Australian and New Zealand women and provides insight into normal circulating levels of 25(OH)D in early pregnancy. It is the largest prospective cohort study to assess vitamin D status within the international SCOPE cohort, comparing and combining two distinct populations of pregnant women living at similar latitude and provides a greater understanding of vitamin D deficiency and the risk of adverse pregnancy outcomes. We found, despite being at similar latitudes, circulating 25(OH)D was different between women recruited in Adelaide compared to women recruited in Auckland. This was independent of diet and lifestyles factors including BMI and SEI and highlights the difficulty in understanding the role of vitamin D in pregnancy in human cohort studies. However, there was a protective association of having high vitamin D at 15âÂ±â1Â weeksâ gestation and GDM once standardised based on month serum was sampled. Furthermore, there may be possible fetal sex specific differences in vitamin D status worth considering in future studies.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23865</offset><text>Despite the similar latitudes of Adelaide and Auckland (Adelaide: 34.93Â°S and Auckland 36.85Â°S), serum 25(OH)D was lower in the women recruited in Adelaide. Given the significant number of characteristic and lifestyle differences between the two populations, this is not overly surprising. Previous studies have shown a positive association between socioeconomic status and vitamin D in both pregnant and non-pregnant women. The lower SEI of the Adelaide women could therefore make them more susceptible to lower circulating 25(OH)D because of factors relating to disadvantage. Furthermore, increased BMI is known to be associated with reduced serum 25(OH)D as adipose tissue is thought to sequester 25(OH)D. However, after adjusting for factors shown to be associated with vitamin D status including BMI and recreational walking, serum 25(OH)D remained significantly lower in the women recruited in Adelaide suggesting the influence of other factors not measured as part of SCOPE for example, hours spent outside in the sun. As indicated by the seasonal variation in serum 25(OH)D, amongst women recruited in Adelaide, vitamin D status declined significantly from February to April whilst in the women recruited in Auckland, serum 25(OH)D in March and April remained elevated before declining.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25162</offset><text>Vitamin D deficiency has previously been associated with insulin resistance and type 2 diabetes given its role in supporting insulin secretion and pancreatic Î²-cell function. Furthermore, inverse relationships between serum 25(OH)D and both fasting glucose and fasting insulin have been shown during pregnancy indicating poorer glycaemic control. Therefore, the protective role of high 25(OH)D 15âÂ±â1Â weeksâ gestation against GDM, as seen with a decreased risk of GDM in women within the âhighâ quartile of standardised vitamin D compared to moderate-high, is consistent with knowledge about vitamin D and diabetes. This is also consistent with another study that observed an increased risk of GDM with vitamin D deficiency in early pregnancy (aOR: 3.40; 95% CI: 2.03â4.98) and offers potential physiological connections between vitamin D status and the progression of insulin resistance in pregnant women. Furthermore, studies have shown that vitamin D supports early placental development in which, abnormal placentation can be a characteristic of a number of pregnancy complications including GDM, PE, sPTB and SGA.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>26296</offset><text>The placenta expresses all the necessary components to convert 25(OH)D to the active form and thus utilise active vitamin D either locally or in a paracrine manner. Vitamin D metabolism in the placenta has been shown to be influenced by testosterone production and thus varies by fetal sex. Furthermore, sex specific differences in pregnancy outcome have also been reported whereby the risk of sPTB, PE and GDM are all higher in pregnancies with a male fetus. In this study, we observed marginal sex-specific differences between early pregnancy vitamin D status and pregnancy outcome where by high vitamin D status and carrying a male fetus was moderately associated with decreasing the risk of having any pregnancy complication. Conversely, high vitamin D status and carrying a female fetus was not associated with changing the risk of having any pregnancy complication. Indeed, for the risk of GDM an opposite effect of vitamin D status in early pregnancy was observed depending on fetal sex. This is similar to that which has previously been shown in the relationship between vitamin D status at â¤26Â weeksâ gestation and placental pathology in pregnancy suggesting that male and female fetuses respond differently to maternal vitamin D status.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>27548</offset><text>Lack of statistically significant associations with other pregnancy complications may reflect the fact that this was a largely vitamin D-replete population (&gt;â72% with serum 25(OH)Dâ&gt;â50Â nmol/L) likely due to their residence latitude as low serum 25(OH)D was found in the SCOPE Ireland cohort. Indeed many of the studies that have assessed the association between vitamin D status and adverse pregnancy outcome that have reported statistically significant differences have been in populations with higher rates of vitamin D deficiency. High dose (&gt;â2000Â IU) vitamin D supplementation is associated with decreasing risk of pregnancy complications. However, routine vitamin D supplementation did not occur during the time period the women in the current study were recruited. Furthermore, multivitamin supplements available during the study period contained very little (maximum 50Â IU), if any, vitamin D and thus areÂ an unlikely source of variation within the population. Inconsistencies in the literature may also reflect other causative factors in which vitamin D is a mediator. For example, active vitamin D (1,25-dihydroxyvitamin D3) is the principal hormone that regulates calcium absorption within the intestine and is integral to maintaining calcium homeostasis. During gestation, fetal demand for calcium increases and it is imperative that maternal vitamin D status remain adequate to support increased calcium absorption from the gut. Therefore, vitamin D status may be important in populations where dietary calcium intake is low which is unlikely in the population of women studied here.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>29159</offset><text>Conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>29171</offset><text>In conclusion, once standardised against month of sampling, we demonstrate a protective effect of high vitamin D with GDM. However, differences in vitamin D status between the women recruited in Adelaide and those recruited in Auckland reflect obvious difficulties in studying how vitamin D may support healthy pregnancies. A possible connection between fetal sex, vitamin D status and pregnancy complications reveals further questions and encourages continual research and discussion into the role of vitamin D in pregnancy, particularly in vitamin D replete populations.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>29744</offset><text>Additional file</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">title</infon><offset>29760</offset><text>Abbreviations</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29774</offset><text>25(OH)D </text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29783</offset><text>25-hydroxy vitamin D</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29804</offset><text>aRR </text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29809</offset><text>adjusted risk ratio</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29829</offset><text>BMI</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29833</offset><text>body mass index</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29849</offset><text>CI</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29852</offset><text>confidence interval</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29872</offset><text>GDM</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29876</offset><text>gestational diabetes mellitus</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29906</offset><text>GH</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29909</offset><text>gestational hypertension</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29934</offset><text>PE</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29937</offset><text>preeclampsia</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29950</offset><text>SCOPE</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29956</offset><text>SCreening fOr Pregnancy Endpoints</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29990</offset><text>SEI</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>29994</offset><text>socioeconomic index</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>30014</offset><text>SGA</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>30018</offset><text>small for gestational age</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>30044</offset><text>sPTB</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>30049</offset><text>spontaneous preterm birth</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">footnote</infon><offset>30075</offset><text>Electronic supplementary material</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">footnote</infon><offset>30109</offset><text>The online version of this article (10.1186/s12884-018-1887-x) contains supplementary material, which is available to authorized users.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>30245</offset><text>Authorsâ contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>30270</offset><text>AJL, PHA, GAD, LM and CTR contributed to the concept and design of this vitamin D association study. GAD, LM and CTR contributed to the design and supervision of the SCOPE study. AJL performed the experiments. RLW and SYL performed the statistical analyses. RLW, PHA, LEG, GAD, TBM and CTR interpreted the data. RLW wrote the manuscript supported by JAG, PEV, LEG and TBM. All authors critically revised the manuscript and approved the final version.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title_1</infon><offset>30721</offset><text>Ethics approval and consent to participate</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>30764</offset><text>This study was approved by the relevant human ethics committees and all participants provided written informed consent (Adelaide: Central Northern Adelaide Health Service Ethics of Human Research Committee on 2 September 2005, ethics number REC 1714/5/2008 and Auckland: Northern Region Ethics Committee on 23 April 2003, ethics number AKX/02/00/364).</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title_1</infon><offset>31116</offset><text>Consent for publication</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>31140</offset><text>Not applicable.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>31156</offset><text>Competing interests</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>31176</offset><text>The authors declare that they have no competing interests.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>31235</offset><text>Publisherâs Note</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>31254</offset><text>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>31373</offset><text>References</text></passage><passage><infon key="fpage">686</infon><infon key="issue">11</infon><infon key="lpage">687</infon><infon key="name_0">surname:Nowson;given-names:CA</infon><infon key="name_1">surname:McGrath;given-names:JJ</infon><infon key="name_2">surname:Ebeling;given-names:PR</infon><infon key="name_3">surname:Haikerwal;given-names:A</infon><infon key="name_4">surname:Daly;given-names:RM</infon><infon key="name_5">surname:Sanders;given-names:KM</infon><infon key="name_6">surname:Seibel;given-names:MJ</infon><infon key="name_7">surname:Mason;given-names:RS</infon><infon key="pub-id_doi">10.5694/mja11.10301</infon><infon key="pub-id_pmid">22708765</infon><infon key="section_type">REF</infon><infon key="source">Med J Aust</infon><infon key="type">ref</infon><infon key="volume">196</infon><infon key="year">2012</infon><offset>31384</offset><text>Vitamin D and health in adults in Australia and New Zealand: a position statement</text></passage><passage><infon key="fpage">f1169</infon><infon key="name_0">surname:Aghajafari;given-names:F</infon><infon key="name_1">surname:Nagulesapillai;given-names:T</infon><infon key="name_2">surname:Ronksley;given-names:PE</infon><infon key="name_3">surname:Tough;given-names:SC</infon><infon key="name_4">surname:O'Beirne;given-names:M</infon><infon key="name_5">surname:Rabi;given-names:DM</infon><infon key="pub-id_doi">10.1136/bmj.f1169</infon><infon key="pub-id_pmid">23533188</infon><infon key="section_type">REF</infon><infon key="source">BMJ</infon><infon key="type">ref</infon><infon key="volume">346</infon><infon key="year">2013</infon><offset>31466</offset><text>Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies</text></passage><passage><infon key="fpage">g1903</infon><infon key="name_0">surname:Chowdhury;given-names:R</infon><infon key="name_1">surname:Kunutsor;given-names:S</infon><infon key="name_2">surname:Vitezova;given-names:A</infon><infon key="name_3">surname:Oliver-Williams;given-names:C</infon><infon key="name_4">surname:Chowdhury;given-names:S</infon><infon key="name_5">surname:Kiefte-de-Jong;given-names:JC</infon><infon key="name_6">surname:Khan;given-names:H</infon><infon key="name_7">surname:Baena;given-names:CP</infon><infon key="name_8">surname:Prabhakaran;given-names:D</infon><infon key="name_9">surname:Hoshen;given-names:MB</infon><infon key="pub-id_doi">10.1136/bmj.g1903</infon><infon key="pub-id_pmid">24690623</infon><infon key="section_type">REF</infon><infon key="source">BMJ</infon><infon key="type">ref</infon><infon key="volume">348</infon><infon key="year">2014</infon><offset>31625</offset><text>Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies</text></passage><passage><infon key="fpage">128</infon><infon key="issue">2</infon><infon key="lpage">139</infon><infon key="name_0">surname:Hollis;given-names:BW</infon><infon key="name_1">surname:Wagner;given-names:CL</infon><infon key="pub-id_doi">10.1007/s00223-012-9607-4</infon><infon key="pub-id_pmid">22623177</infon><infon key="section_type">REF</infon><infon key="source">Calcif Tissue Int</infon><infon key="type">ref</infon><infon key="volume">92</infon><infon key="year">2013</infon><offset>31765</offset><text>Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes</text></passage><passage><infon key="fpage">1357</infon><infon key="issue">12</infon><infon key="lpage">1367</infon><infon key="name_0">surname:Christesen;given-names:HT</infon><infon key="name_1">surname:Falkenberg;given-names:T</infon><infon key="name_2">surname:Lamont;given-names:RF</infon><infon key="name_3">surname:Jorgensen;given-names:JS</infon><infon key="pub-id_doi">10.1111/aogs.12000</infon><infon key="pub-id_pmid">22974137</infon><infon key="section_type">REF</infon><infon key="source">Acta Obstet Gynecol Scand</infon><infon key="type">ref</infon><infon key="volume">91</infon><infon key="year">2012</infon><offset>31848</offset><text>The impact of vitamin D on pregnancy: a systematic review</text></passage><passage><infon key="fpage">57</infon><infon key="issue">2</infon><infon key="lpage">64</infon><infon key="name_0">surname:Urrutia;given-names:RP</infon><infon key="name_1">surname:Thorp;given-names:JM</infon><infon key="pub-id_doi">10.1097/GCO.0b013e3283505ab3</infon><infon key="pub-id_pmid">22327734</infon><infon key="section_type">REF</infon><infon key="source">Curr Opin Obstet Gynecol</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2012</infon><offset>31906</offset><text>Vitamin D in pregnancy: current concepts</text></passage><passage><infon key="fpage">142</infon><infon key="issue">3</infon><infon key="lpage">143</infon><infon key="name_0">surname:Paxton;given-names:GA</infon><infon key="name_1">surname:Teale;given-names:GR</infon><infon key="name_2">surname:Nowson;given-names:CA</infon><infon key="name_3">surname:Mason;given-names:RS</infon><infon key="name_4">surname:McGrath;given-names:JJ</infon><infon key="name_5">surname:Thompson;given-names:MJ</infon><infon key="name_6">surname:Siafarikas;given-names:A</infon><infon key="name_7">surname:Rodda;given-names:CP</infon><infon key="name_8">surname:Munns;given-names:CF</infon><infon key="pub-id_doi">10.5694/mja11.11592</infon><infon key="pub-id_pmid">23418693</infon><infon key="section_type">REF</infon><infon key="source">Med J Aust</infon><infon key="type">ref</infon><infon key="volume">198</infon><infon key="year">2013</infon><offset>31947</offset><text>Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement</text></passage><passage><infon key="fpage">251</infon><infon key="issue">5</infon><infon key="lpage">252</infon><infon key="name_0">surname:Grover;given-names:SR</infon><infon key="name_1">surname:Morley;given-names:R</infon><infon key="pub-id_pmid">11587255</infon><infon key="section_type">REF</infon><infon key="source">Med J Aust</infon><infon key="type">ref</infon><infon key="volume">175</infon><infon key="year">2001</infon><offset>32067</offset><text>Vitamin D deficiency in veiled or dark-skinned pregnant women</text></passage><passage><infon key="fpage">372</infon><infon key="issue">3</infon><infon key="lpage">377</infon><infon key="name_0">surname:Bowyer;given-names:L</infon><infon key="name_1">surname:Catling-Paull;given-names:C</infon><infon key="name_2">surname:Diamond;given-names:T</infon><infon key="name_3">surname:Homer;given-names:C</infon><infon key="name_4">surname:Davis;given-names:G</infon><infon key="name_5">surname:Craig;given-names:ME</infon><infon key="pub-id_doi">10.1111/j.1365-2265.2008.03316.x</infon><infon key="section_type">REF</infon><infon key="source">Clin Endocrinol</infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">2009</infon><offset>32129</offset><text>Vitamin D, PTH and calcium levels in pregnant women and their neonates</text></passage><passage><infon key="fpage">U2144</infon><infon key="issue">1241</infon><infon key="name_0">surname:Judkins;given-names:A</infon><infon key="name_1">surname:Eagleton;given-names:C</infon><infon key="pub-id_pmid">16964296</infon><infon key="section_type">REF</infon><infon key="source">N Z Med J</infon><infon key="type">ref</infon><infon key="volume">119</infon><infon key="year">2006</infon><offset>32200</offset><text>Vitamin D deficiency in pregnant New Zealand women</text></passage><passage><infon key="fpage">259</infon><infon key="issue">3</infon><infon key="lpage">261</infon><infon key="name_0">surname:Teale;given-names:GR</infon><infon key="name_1">surname:Cunningham;given-names:CE</infon><infon key="pub-id_doi">10.1111/j.1479-828X.2010.01147.x</infon><infon key="pub-id_pmid">20618244</infon><infon key="section_type">REF</infon><infon key="source">Aust N Z J Obstet Gynaecol</infon><infon key="type">ref</infon><infon key="volume">50</infon><infon key="year">2010</infon><offset>32251</offset><text>Vitamin D deficiency is common among pregnant women in rural Victoria</text></passage><passage><infon key="fpage">149</infon><infon key="issue">2</infon><infon key="lpage">155</infon><infon key="name_0">surname:Davies-Tuck;given-names:M</infon><infon key="name_1">surname:Yim;given-names:C</infon><infon key="name_2">surname:Knight;given-names:M</infon><infon key="name_3">surname:Hodges;given-names:R</infon><infon key="name_4">surname:Doery;given-names:JC</infon><infon key="name_5">surname:Wallace;given-names:E</infon><infon key="pub-id_doi">10.1111/ajo.12278</infon><infon key="pub-id_pmid">25900732</infon><infon key="section_type">REF</infon><infon key="source">Aust N Z J Obstet Gynaecol</infon><infon key="type">ref</infon><infon key="volume">55</infon><infon key="year">2015</infon><offset>32321</offset><text>Vitamin D testing in pregnancy: does one size fit all?</text></passage><passage><infon key="fpage">353</infon><infon key="issue">4</infon><infon key="lpage">359</infon><infon key="name_0">surname:Perampalam;given-names:S</infon><infon key="name_1">surname:Ganda;given-names:K</infon><infon key="name_2">surname:Chow;given-names:KA</infon><infon key="name_3">surname:Opie;given-names:N</infon><infon key="name_4">surname:Hickman;given-names:PE</infon><infon key="name_5">surname:Shadbolt;given-names:B</infon><infon key="name_6">surname:Hennessy;given-names:A</infon><infon key="name_7">surname:Grunstein;given-names:H</infon><infon key="name_8">surname:Nolan;given-names:CJ</infon><infon key="pub-id_doi">10.1111/j.1479-828X.2011.01313.x</infon><infon key="pub-id_pmid">21806574</infon><infon key="section_type">REF</infon><infon key="source">Aust N Z J Obstet Gynaecol</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2011</infon><offset>32376</offset><text>Vitamin D status and its predictive factors in pregnancy in 2 Australian populations</text></passage><passage><infon key="fpage">4702</infon><infon key="issue">12</infon><infon key="lpage">4715</infon><infon key="name_0">surname:Mirzakhani;given-names:H</infon><infon key="name_1">surname:Litonjua;given-names:AA</infon><infon key="name_2">surname:McElrath;given-names:TF</infon><infon key="name_3">surname:O'Connor;given-names:G</infon><infon key="name_4">surname:Lee-Parritz;given-names:A</infon><infon key="name_5">surname:Iverson;given-names:R</infon><infon key="name_6">surname:Macones;given-names:G</infon><infon key="name_7">surname:Strunk;given-names:RC</infon><infon key="name_8">surname:Bacharier;given-names:LB</infon><infon key="name_9">surname:Zeiger;given-names:R</infon><infon key="pub-id_doi">10.1172/JCI89031</infon><infon key="pub-id_pmid">27841759</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">126</infon><infon key="year">2016</infon><offset>32461</offset><text>Early pregnancy vitamin D status and risk of preeclampsia</text></passage><passage><infon key="fpage">e0180483</infon><infon key="issue">7</infon><infon key="name_0">surname:McDonnell;given-names:SL</infon><infon key="name_1">surname:Baggerly;given-names:KA</infon><infon key="name_2">surname:Baggerly;given-names:CA</infon><infon key="name_3">surname:Aliano;given-names:JL</infon><infon key="name_4">surname:French;given-names:CB</infon><infon key="name_5">surname:Baggerly;given-names:LL</infon><infon key="name_6">surname:Ebeling;given-names:MD</infon><infon key="name_7">surname:Rittenberg;given-names:CS</infon><infon key="name_8">surname:Goodier;given-names:CG</infon><infon key="name_9">surname:Mateus Nino;given-names:JF</infon><infon key="pub-id_doi">10.1371/journal.pone.0180483</infon><infon key="pub-id_pmid">28738090</infon><infon key="section_type">REF</infon><infon key="source">PLoS One</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2017</infon><offset>32519</offset><text>Maternal 25(OH)D concentrations &gt;/=40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center</text></passage><passage><infon key="fpage">245</infon><infon key="issue">Pt B</infon><infon key="lpage">251</infon><infon key="name_0">surname:Wagner;given-names:CL</infon><infon key="name_1">surname:Baggerly;given-names:C</infon><infon key="name_2">surname:McDonnell;given-names:S</infon><infon key="name_3">surname:Baggerly;given-names:KA</infon><infon key="name_4">surname:French;given-names:CB</infon><infon key="name_5">surname:Baggerly;given-names:L</infon><infon key="name_6">surname:Hamilton;given-names:SA</infon><infon key="name_7">surname:Hollis;given-names:BW</infon><infon key="pub-id_doi">10.1016/j.jsbmb.2015.10.022</infon><infon key="pub-id_pmid">26554936</infon><infon key="section_type">REF</infon><infon key="source">J Steroid Biochem Mol Biol</infon><infon key="type">ref</infon><infon key="volume">155</infon><infon key="year">2016</infon><offset>32670</offset><text>Post-hoc analysis of vitamin D status and reduced risk of preterm birth in two vitamin D pregnancy cohorts compared with South Carolina March of Dimes 2009-2011 rates</text></passage><passage><infon key="fpage">280</infon><infon key="issue">3</infon><infon key="lpage">286</infon><infon key="name_0">surname:Xu;given-names:C</infon><infon key="name_1">surname:Ma;given-names:HH</infon><infon key="name_2">surname:Wang;given-names:Y</infon><infon key="pub-id_doi">10.1007/s00223-017-0346-4</infon><infon key="pub-id_pmid">29058058</infon><infon key="section_type">REF</infon><infon key="source">Calcif Tissue Int</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="year">2018</infon><offset>32837</offset><text>Maternal early pregnancy plasma concentration of 25-Hydroxyvitamin D and risk of gestational diabetes mellitus</text></passage><passage><infon key="fpage">287</infon><infon key="issue">2</infon><infon key="lpage">295</infon><infon key="name_0">surname:Schneuer;given-names:FJ</infon><infon key="name_1">surname:Roberts;given-names:CL</infon><infon key="name_2">surname:Guilbert;given-names:C</infon><infon key="name_3">surname:Simpson;given-names:JM</infon><infon key="name_4">surname:Algert;given-names:CS</infon><infon key="name_5">surname:Khambalia;given-names:AZ</infon><infon key="name_6">surname:Tasevski;given-names:V</infon><infon key="name_7">surname:Ashton;given-names:AW</infon><infon key="name_8">surname:Morris;given-names:JM</infon><infon key="name_9">surname:Nassar;given-names:N</infon><infon key="pub-id_doi">10.3945/ajcn.113.065672</infon><infon key="pub-id_pmid">24257720</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">99</infon><infon key="year">2014</infon><offset>32948</offset><text>Effects of maternal serum 25-hydroxyvitamin D concentrations in the first trimester on subsequent pregnancy outcomes in an Australian population</text></passage><passage><infon key="fpage">678</infon><infon key="issue">6</infon><infon key="lpage">684</infon><infon key="name_0">surname:Clifton-Bligh;given-names:RJ</infon><infon key="name_1">surname:McElduff;given-names:P</infon><infon key="name_2">surname:McElduff;given-names:A</infon><infon key="pub-id_doi">10.1111/j.1464-5491.2008.02422.x</infon><infon key="pub-id_pmid">18544105</infon><infon key="section_type">REF</infon><infon key="source">Diabet Med</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2008</infon><offset>33093</offset><text>Maternal vitamin D deficiency, ethnicity and gestational diabetes</text></passage><passage><infon key="fpage">1409</infon><infon key="issue">8</infon><infon key="lpage">1415</infon><infon key="name_0">surname:Boyle;given-names:VT</infon><infon key="name_1">surname:Thorstensen;given-names:EB</infon><infon key="name_2">surname:Mourath;given-names:D</infon><infon key="name_3">surname:Jones;given-names:MB</infon><infon key="name_4">surname:McCowan;given-names:LM</infon><infon key="name_5">surname:Kenny;given-names:LC</infon><infon key="name_6">surname:Baker;given-names:PN</infon><infon key="pub-id_doi">10.1017/S0007114516003202</infon><infon key="pub-id_pmid">27753425</infon><infon key="section_type">REF</infon><infon key="source">Br J Nutr</infon><infon key="type">ref</infon><infon key="volume">116</infon><infon key="year">2016</infon><offset>33159</offset><text>The relationship between 25-hydroxyvitamin D concentration in early pregnancy and pregnancy outcomes in a large, prospective cohort</text></passage><passage><infon key="fpage">21</infon><infon key="issue">1</infon><infon key="lpage">32</infon><infon key="name_0">surname:Martin;given-names:CA</infon><infon key="name_1">surname:Gowda;given-names:U</infon><infon key="name_2">surname:Renzaho;given-names:AM</infon><infon key="pub-id_doi">10.1016/j.nut.2015.07.007</infon><infon key="pub-id_pmid">26643747</infon><infon key="section_type">REF</infon><infon key="source">Nutrition</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2016</infon><offset>33291</offset><text>The prevalence of vitamin D deficiency among dark-skinned populations according to their stage of migration and region of birth: a meta-analysis</text></passage><passage><infon key="fpage">365</infon><infon key="issue">1</infon><infon key="lpage">408</infon><infon key="name_0">surname:Christakos;given-names:S</infon><infon key="name_1">surname:Dhawan;given-names:P</infon><infon key="name_2">surname:Verstuyf;given-names:A</infon><infon key="name_3">surname:Verlinden;given-names:L</infon><infon key="name_4">surname:Carmeliet;given-names:G</infon><infon key="pub-id_doi">10.1152/physrev.00014.2015</infon><infon key="pub-id_pmid">26681795</infon><infon key="section_type">REF</infon><infon key="source">Physiol Rev</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">2016</infon><offset>33436</offset><text>Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects</text></passage><passage><infon key="fpage">2341</infon><infon key="issue">10</infon><infon key="lpage">2357</infon><infon key="name_0">surname:Hollis;given-names:BW</infon><infon key="name_1">surname:Johnson;given-names:D</infon><infon key="name_2">surname:Hulsey;given-names:TC</infon><infon key="name_3">surname:Ebeling;given-names:M</infon><infon key="name_4">surname:Wagner;given-names:CL</infon><infon key="pub-id_doi">10.1002/jbmr.463</infon><infon key="pub-id_pmid">21706518</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2011</infon><offset>33514</offset><text>Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness</text></passage><passage><infon key="fpage">536</infon><infon key="issue">4</infon><infon key="lpage">541</infon><infon key="name_0">surname:Sablok;given-names:A</infon><infon key="name_1">surname:Batra;given-names:A</infon><infon key="name_2">surname:Thariani;given-names:K</infon><infon key="name_3">surname:Batra;given-names:A</infon><infon key="name_4">surname:Bharti;given-names:R</infon><infon key="name_5">surname:Aggarwal;given-names:AR</infon><infon key="name_6">surname:Kabi;given-names:BC</infon><infon key="name_7">surname:Chellani;given-names:H</infon><infon key="pub-id_doi">10.1111/cen.12751</infon><infon key="section_type">REF</infon><infon key="source">Clin Endocrinol</infon><infon key="type">ref</infon><infon key="volume">83</infon><infon key="year">2015</infon><offset>33626</offset><text>Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome</text></passage><passage><infon key="fpage">313</infon><infon key="lpage">320</infon><infon key="name_0">surname:Wagner;given-names:CL</infon><infon key="name_1">surname:McNeil;given-names:RB</infon><infon key="name_2">surname:Johnson;given-names:DD</infon><infon key="name_3">surname:Hulsey;given-names:TC</infon><infon key="name_4">surname:Ebeling;given-names:M</infon><infon key="name_5">surname:Robinson;given-names:C</infon><infon key="name_6">surname:Hamilton;given-names:SA</infon><infon key="name_7">surname:Hollis;given-names:BW</infon><infon key="pub-id_doi">10.1016/j.jsbmb.2013.01.002</infon><infon key="pub-id_pmid">23314242</infon><infon key="section_type">REF</infon><infon key="source">J Steroid Biochem Mol Biol</infon><infon key="type">ref</infon><infon key="volume">136</infon><infon key="year">2013</infon><offset>33715</offset><text>Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis</text></passage><passage><infon key="fpage">256</infon><infon key="lpage">260</infon><infon key="name_0">surname:Wagner;given-names:CL</infon><infon key="name_1">surname:Baggerly;given-names:C</infon><infon key="name_2">surname:McDonnell;given-names:SL</infon><infon key="name_3">surname:Baggerly;given-names:L</infon><infon key="name_4">surname:Hamilton;given-names:SA</infon><infon key="name_5">surname:Winkler;given-names:J</infon><infon key="name_6">surname:Warner;given-names:G</infon><infon key="name_7">surname:Rodriguez;given-names:C</infon><infon key="name_8">surname:Shary;given-names:JR</infon><infon key="name_9">surname:Smith;given-names:PG</infon><infon key="pub-id_doi">10.1016/j.jsbmb.2014.11.013</infon><infon key="pub-id_pmid">25448734</infon><infon key="section_type">REF</infon><infon key="source">J Steroid Biochem Mol Biol</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2015</infon><offset>33840</offset><text>Post-hoc comparison of vitamin D status at three timepoints during pregnancy demonstrates lower risk of preterm birth with higher vitamin D closer to delivery</text></passage><passage><infon key="fpage">159</infon><infon key="issue">Pt 2</infon><infon key="lpage">165</infon><infon key="name_0">surname:Cluse;given-names:ZN</infon><infon key="name_1">surname:Fudge;given-names:AN</infon><infon key="name_2">surname:Whiting;given-names:MJ</infon><infon key="name_3">surname:McWhinney;given-names:B</infon><infon key="name_4">surname:Parkinson;given-names:I</infon><infon key="name_5">surname:O'Loughlin;given-names:PD</infon><infon key="pub-id_doi">10.1258/acb.2011.011018</infon><infon key="pub-id_pmid">22155920</infon><infon key="section_type">REF</infon><infon key="source">Ann Clin Biochem</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="year">2012</infon><offset>33999</offset><text>Evaluation of 25-hydroxy vitamin D assay on the immunodiagnostic systems iSYS analyser</text></passage><passage><infon key="fpage">644</infon><infon key="issue">3</infon><infon key="lpage">652</infon><infon key="name_0">surname:Kenny;given-names:LC</infon><infon key="name_1">surname:Black;given-names:MA</infon><infon key="name_2">surname:Poston;given-names:L</infon><infon key="name_3">surname:Taylor;given-names:R</infon><infon key="name_4">surname:Myers;given-names:JE</infon><infon key="name_5">surname:Baker;given-names:PN</infon><infon key="name_6">surname:McCowan;given-names:LM</infon><infon key="name_7">surname:Simpson;given-names:NA</infon><infon key="name_8">surname:Dekker;given-names:GA</infon><infon key="name_9">surname:Roberts;given-names:CT</infon><infon key="pub-id_doi">10.1161/HYPERTENSIONAHA.114.03578</infon><infon key="pub-id_pmid">25122928</infon><infon key="section_type">REF</infon><infon key="source">Hypertension</infon><infon key="type">ref</infon><infon key="volume">64</infon><infon key="year">2014</infon><offset>34086</offset><text>Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for pregnancy endpoints (SCOPE) international cohort study</text></passage><passage><infon key="fpage">1599</infon><infon key="issue">13</infon><infon key="lpage">1607</infon><infon key="name_0">surname:McCowan;given-names:LM</infon><infon key="name_1">surname:Roberts;given-names:CT</infon><infon key="name_2">surname:Dekker;given-names:GA</infon><infon key="name_3">surname:Taylor;given-names:RS</infon><infon key="name_4">surname:Chan;given-names:EH</infon><infon key="name_5">surname:Kenny;given-names:LC</infon><infon key="name_6">surname:Baker;given-names:PN</infon><infon key="name_7">surname:Moss-Morris;given-names:R</infon><infon key="name_8">surname:Chappell;given-names:LC</infon><infon key="name_9">surname:North;given-names:RA</infon><infon key="pub-id_doi">10.1111/j.1471-0528.2010.02737.x</infon><infon key="pub-id_pmid">21078055</infon><infon key="section_type">REF</infon><infon key="source">BJOG</infon><infon key="type">ref</infon><infon key="volume">117</infon><infon key="year">2010</infon><offset>34264</offset><text>Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study</text></passage><passage><infon key="fpage">27</infon><infon key="issue">1</infon><infon key="lpage">33</infon><infon key="name_0">surname:Davis;given-names:P</infon><infon key="name_1">surname:McLeod;given-names:K</infon><infon key="name_2">surname:Ransom;given-names:M</infon><infon key="name_3">surname:Ongley;given-names:P</infon><infon key="name_4">surname:Pearce;given-names:N</infon><infon key="name_5">surname:Howden-Chapman;given-names:P</infon><infon key="pub-id_doi">10.1111/j.1467-842X.1999.tb01201.x</infon><infon key="pub-id_pmid">10083686</infon><infon key="section_type">REF</infon><infon key="source">Aust N Z J Public Health</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">1999</infon><offset>34403</offset><text>The New Zealand socioeconomic index: developing and validating an occupationally-derived indicator of socio-economic status</text></passage><passage><infon key="fpage">b1081</infon><infon key="name_0">surname:McCowan;given-names:LM</infon><infon key="name_1">surname:Dekker;given-names:GA</infon><infon key="name_2">surname:Chan;given-names:E</infon><infon key="name_3">surname:Stewart;given-names:A</infon><infon key="name_4">surname:Chappell;given-names:LC</infon><infon key="name_5">surname:Hunter;given-names:M</infon><infon key="name_6">surname:Moss-Morris;given-names:R</infon><infon key="name_7">surname:North;given-names:RA</infon><infon key="pub-id_doi">10.1136/bmj.b1081</infon><infon key="pub-id_pmid">19325177</infon><infon key="section_type">REF</infon><infon key="source">BMJ</infon><infon key="type">ref</infon><infon key="volume">338</infon><infon key="year">2009</infon><offset>34527</offset><text>Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>34662</offset><text>International Association of D, pregnancy study groups consensus P, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, dyer AR, Leiva a et al: International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33(3):676â682.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>35006</offset><text>Team RDC: R: A Language and Environment for Statistical Computing In. Vienna, Austria: R Foundation for Statistical Computing; 2011.</text></passage><passage><infon key="fpage">1223</infon><infon key="issue">10</infon><infon key="lpage">1232</infon><infon key="name_0">surname:Travis;given-names:RC</infon><infon key="name_1">surname:Crowe;given-names:FL</infon><infon key="name_2">surname:Allen;given-names:NE</infon><infon key="name_3">surname:Appleby;given-names:PN</infon><infon key="name_4">surname:Roddam;given-names:AW</infon><infon key="name_5">surname:Tjonneland;given-names:A</infon><infon key="name_6">surname:Olsen;given-names:A</infon><infon key="name_7">surname:Linseisen;given-names:J</infon><infon key="name_8">surname:Kaaks;given-names:R</infon><infon key="name_9">surname:Boeing;given-names:H</infon><infon key="pub-id_doi">10.1093/aje/kwp022</infon><infon key="pub-id_pmid">19359375</infon><infon key="section_type">REF</infon><infon key="source">Am J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">169</infon><infon key="year">2009</infon><offset>35139</offset><text>Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European prospective investigation into Cancer and nutrition (EPIC)</text></passage><passage><infon key="fpage">173</infon><infon key="lpage">182</infon><infon key="name_0">surname:Olmos-Ortiz;given-names:A</infon><infon key="name_1">surname:Garcia-Quiroz;given-names:J</infon><infon key="name_2">surname:Lopez-Marure;given-names:R</infon><infon key="name_3">surname:Gonzalez-Curiel;given-names:I</infon><infon key="name_4">surname:Rivas-Santiago;given-names:B</infon><infon key="name_5">surname:Olivares;given-names:A</infon><infon key="name_6">surname:Avila;given-names:E</infon><infon key="name_7">surname:Barrera;given-names:D</infon><infon key="name_8">surname:Halhali;given-names:A</infon><infon key="name_9">surname:Caldino;given-names:F</infon><infon key="pub-id_doi">10.1016/j.jsbmb.2016.05.017</infon><infon key="pub-id_pmid">27210415</infon><infon key="section_type">REF</infon><infon key="source">J Steroid Biochem Mol Biol</infon><infon key="type">ref</infon><infon key="volume">163</infon><infon key="year">2016</infon><offset>35296</offset><text>Evidence of sexual dimorphism in placental vitamin D metabolism: testosterone inhibits calcitriol-dependent cathelicidin expression</text></passage><passage><infon key="fpage">641</infon><infon key="name_0">surname:Rabenberg;given-names:M</infon><infon key="name_1">surname:Scheidt-Nave;given-names:C</infon><infon key="name_2">surname:Busch;given-names:MA</infon><infon key="name_3">surname:Rieckmann;given-names:N</infon><infon key="name_4">surname:Hintzpeter;given-names:B</infon><infon key="name_5">surname:Mensink;given-names:GB</infon><infon key="pub-id_doi">10.1186/s12889-015-2016-7</infon><infon key="pub-id_pmid">26162848</infon><infon key="section_type">REF</infon><infon key="source">BMC Public Health</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2015</infon><offset>35428</offset><text>Vitamin D status among adults in Germany--results from the German health interview and examination survey for adults (DEGS1)</text></passage><passage><infon key="fpage">217</infon><infon key="issue">3</infon><infon key="lpage">228</infon><infon key="name_0">surname:Rodriguez;given-names:A</infon><infon key="name_1">surname:Santa Marina;given-names:L</infon><infon key="name_2">surname:Jimenez;given-names:AM</infon><infon key="name_3">surname:Esplugues;given-names:A</infon><infon key="name_4">surname:Ballester;given-names:F</infon><infon key="name_5">surname:Espada;given-names:M</infon><infon key="name_6">surname:Sunyer;given-names:J</infon><infon key="name_7">surname:Morales;given-names:E</infon><infon key="pub-id_doi">10.1111/ppe.12281</infon><infon key="pub-id_pmid">26849093</infon><infon key="section_type">REF</infon><infon key="source">Paediatr Perinat Epidemiol</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2016</infon><offset>35553</offset><text>Vitamin D status in pregnancy and determinants in a southern European cohort study</text></passage><passage><infon key="fpage">157</infon><infon key="issue">1</infon><infon key="lpage">161</infon><infon key="name_0">surname:Arunabh;given-names:S</infon><infon key="name_1">surname:Pollack;given-names:S</infon><infon key="name_2">surname:Yeh;given-names:J</infon><infon key="name_3">surname:Aloia;given-names:JF</infon><infon key="pub-id_doi">10.1210/jc.2002-020978</infon><infon key="pub-id_pmid">12519845</infon><infon key="section_type">REF</infon><infon key="source">J Clin Endocrinol Metab</infon><infon key="type">ref</infon><infon key="volume">88</infon><infon key="year">2003</infon><offset>35636</offset><text>Body fat content and 25-hydroxyvitamin D levels in healthy women</text></passage><passage><infon key="fpage">2437</infon><infon key="issue">11</infon><infon key="lpage">2442</infon><infon key="name_0">surname:Bodnar;given-names:LM</infon><infon key="name_1">surname:Catov;given-names:JM</infon><infon key="name_2">surname:Roberts;given-names:JM</infon><infon key="name_3">surname:Simhan;given-names:HN</infon><infon key="pub-id_doi">10.1093/jn/137.11.2437</infon><infon key="pub-id_pmid">17951482</infon><infon key="section_type">REF</infon><infon key="source">J Nutr</infon><infon key="type">ref</infon><infon key="volume">137</infon><infon key="year">2007</infon><offset>35701</offset><text>Prepregnancy obesity predicts poor vitamin D status in mothers and their neonates</text></passage><passage><infon key="fpage">535</infon><infon key="issue">4</infon><infon key="lpage">541</infon><infon key="name_0">surname:McKinney;given-names:K</infon><infon key="name_1">surname:Breitkopf;given-names:CR</infon><infon key="name_2">surname:Berenson;given-names:AB</infon><infon key="pub-id_doi">10.1111/j.1365-2265.2008.03233.x</infon><infon key="section_type">REF</infon><infon key="source">Clin Endocrinol</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">2008</infon><offset>35783</offset><text>Association of race, body fat and season with vitamin D status among young women: a cross-sectional study</text></passage><passage><infon key="fpage">690</infon><infon key="issue">3</infon><infon key="lpage">693</infon><infon key="name_0">surname:Wortsman;given-names:J</infon><infon key="name_1">surname:Matsuoka;given-names:LY</infon><infon key="name_2">surname:Chen;given-names:TC</infon><infon key="name_3">surname:Lu;given-names:Z</infon><infon key="name_4">surname:Holick;given-names:MF</infon><infon key="pub-id_doi">10.1093/ajcn/72.3.690</infon><infon key="pub-id_pmid">10966885</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">72</infon><infon key="year">2000</infon><offset>35889</offset><text>Decreased bioavailability of vitamin D in obesity</text></passage><passage><infon key="fpage">185</infon><infon key="issue">3</infon><infon key="lpage">197</infon><infon key="name_0">surname:Palomer;given-names:X</infon><infon key="name_1">surname:Gonzalez-Clemente;given-names:JM</infon><infon key="name_2">surname:Blanco-Vaca;given-names:F</infon><infon key="name_3">surname:Mauricio;given-names:D</infon><infon key="pub-id_doi">10.1111/j.1463-1326.2007.00710.x</infon><infon key="pub-id_pmid">18269634</infon><infon key="section_type">REF</infon><infon key="source">Diabetes Obes Metab</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2008</infon><offset>35939</offset><text>Role of vitamin D in the pathogenesis of type 2 diabetes mellitus</text></passage><passage><infon key="fpage">334</infon><infon key="issue">7</infon><infon key="lpage">337</infon><infon key="name_0">surname:Lau;given-names:SL</infon><infon key="name_1">surname:Gunton;given-names:JE</infon><infon key="name_2">surname:Athayde;given-names:NP</infon><infon key="name_3">surname:Byth;given-names:K</infon><infon key="name_4">surname:Cheung;given-names:NW</infon><infon key="pub-id_pmid">21470081</infon><infon key="section_type">REF</infon><infon key="source">Med J Aust</infon><infon key="type">ref</infon><infon key="volume">194</infon><infon key="year">2011</infon><offset>36005</offset><text>Serum 25-hydroxyvitamin D and glycated haemoglobin levels in women with gestational diabetes mellitus</text></passage><passage><infon key="fpage">14838</infon><infon key="issue">22</infon><infon key="lpage">14848</infon><infon key="name_0">surname:Novakovic;given-names:B</infon><infon key="name_1">surname:Sibson;given-names:M</infon><infon key="name_2">surname:Ng;given-names:HK</infon><infon key="name_3">surname:Manuelpillai;given-names:U</infon><infon key="name_4">surname:Rakyan;given-names:V</infon><infon key="name_5">surname:Down;given-names:T</infon><infon key="name_6">surname:Beck;given-names:S</infon><infon key="name_7">surname:Fournier;given-names:T</infon><infon key="name_8">surname:Evain-Brion;given-names:D</infon><infon key="name_9">surname:Dimitriadis;given-names:E</infon><infon key="pub-id_doi">10.1074/jbc.M809542200</infon><infon key="pub-id_pmid">19237542</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">284</infon><infon key="year">2009</infon><offset>36107</offset><text>Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface</text></passage><passage><infon key="fpage">80</infon><infon key="issue">2</infon><infon key="lpage">84</infon><infon key="name_0">surname:Fischer;given-names:D</infon><infon key="name_1">surname:Schroer;given-names:A</infon><infon key="name_2">surname:Ludders;given-names:D</infon><infon key="name_3">surname:Cordes;given-names:T</infon><infon key="name_4">surname:Bucker;given-names:B</infon><infon key="name_5">surname:Reichrath;given-names:J</infon><infon key="name_6">surname:Friedrich;given-names:M</infon><infon key="pub-id_pmid">17629157</infon><infon key="section_type">REF</infon><infon key="source">Clin Exp Obstet Gynecol</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">2007</infon><offset>36273</offset><text>Metabolism of vitamin D3 in the placental tissue of normal and preeclampsia complicated pregnancies and premature births</text></passage><passage><infon key="fpage">193</infon><infon key="issue">3</infon><infon key="lpage">201</infon><infon key="name_0">surname:Brosens;given-names:I</infon><infon key="name_1">surname:Pijnenborg;given-names:R</infon><infon key="name_2">surname:Vercruysse;given-names:L</infon><infon key="name_3">surname:Romero;given-names:R</infon><infon key="pub-id_doi">10.1016/j.ajog.2010.08.009</infon><infon key="pub-id_pmid">21094932</infon><infon key="section_type">REF</infon><infon key="source">Am J Obstet Gynecol</infon><infon key="type">ref</infon><infon key="volume">204</infon><infon key="year">2011</infon><offset>36394</offset><text>The &quot;great obstetrical syndromes&quot; are associated with disorders of deep placentation</text></passage><passage><infon key="fpage">1027</infon><infon key="issue">12</infon><infon key="lpage">1034</infon><infon key="name_0">surname:Shin;given-names:JS</infon><infon key="name_1">surname:Choi;given-names:MY</infon><infon key="name_2">surname:Longtine;given-names:MS</infon><infon key="name_3">surname:Nelson;given-names:DM</infon><infon key="pub-id_doi">10.1016/j.placenta.2010.08.015</infon><infon key="pub-id_pmid">20863562</infon><infon key="section_type">REF</infon><infon key="source">Placenta</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">2010</infon><offset>36479</offset><text>Vitamin D effects on pregnancy and the placenta</text></passage><passage><infon key="fpage">271</infon><infon key="issue">3</infon><infon key="lpage">276</infon><infon key="name_0">surname:Aibar;given-names:L</infon><infon key="name_1">surname:Puertas;given-names:A</infon><infon key="name_2">surname:Valverde;given-names:M</infon><infon key="name_3">surname:Carrillo;given-names:MP</infon><infon key="name_4">surname:Montoya;given-names:F</infon><infon key="pub-id_doi">10.1515/jpm-2011-0137</infon><infon key="pub-id_pmid">22505506</infon><infon key="section_type">REF</infon><infon key="source">J Perinat Med</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">2012</infon><offset>36527</offset><text>Fetal sex and perinatal outcomes</text></passage><passage><infon key="fpage">338</infon><infon key="issue">4</infon><infon key="lpage">344</infon><infon key="name_0">surname:Melamed;given-names:N</infon><infon key="name_1">surname:Yogev;given-names:Y</infon><infon key="name_2">surname:Glezerman;given-names:M</infon><infon key="pub-id_doi">10.3109/14767050903300969</infon><infon key="pub-id_pmid">20222831</infon><infon key="section_type">REF</infon><infon key="source">J Matern Fetal Neonatal Med</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2010</infon><offset>36560</offset><text>Fetal gender and pregnancy outcome</text></passage><passage><infon key="fpage">e0158807</infon><infon key="issue">7</infon><infon key="name_0">surname:Verburg;given-names:PE</infon><infon key="name_1">surname:Tucker;given-names:G</infon><infon key="name_2">surname:Scheil;given-names:W</infon><infon key="name_3">surname:Erwich;given-names:JJ</infon><infon key="name_4">surname:Dekker;given-names:GA</infon><infon key="name_5">surname:Roberts;given-names:CT</infon><infon key="pub-id_doi">10.1371/journal.pone.0158807</infon><infon key="pub-id_pmid">27398996</infon><infon key="section_type">REF</infon><infon key="source">PLoS One</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2016</infon><offset>36595</offset><text>Sexual dimorphism in adverse pregnancy outcomes - a retrospective Australian population study 1981-2011</text></passage><passage><infon key="fpage">383</infon><infon key="issue">2</infon><infon key="lpage">388</infon><infon key="name_0">surname:Gernand;given-names:AD</infon><infon key="name_1">surname:Bodnar;given-names:LM</infon><infon key="name_2">surname:Klebanoff;given-names:MA</infon><infon key="name_3">surname:Parks;given-names:WT</infon><infon key="name_4">surname:Simhan;given-names:HN</infon><infon key="pub-id_doi">10.3945/ajcn.112.055426</infon><infon key="pub-id_pmid">23803889</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">98</infon><infon key="year">2013</infon><offset>36699</offset><text>Maternal serum 25-hydroxyvitamin D and placental vascular pathology in a multicenter US cohort</text></passage><passage><infon key="fpage">354</infon><infon key="issue">2</infon><infon key="lpage">361</infon><infon key="name_0">surname:Kiely;given-names:ME</infon><infon key="name_1">surname:Zhang;given-names:JY</infon><infon key="name_2">surname:Kinsella;given-names:M</infon><infon key="name_3">surname:Khashan;given-names:AS</infon><infon key="name_4">surname:Kenny;given-names:LC</infon><infon key="pub-id_doi">10.3945/ajcn.116.130419</infon><infon key="pub-id_pmid">27357092</infon><infon key="section_type">REF</infon><infon key="source">Am J Clin Nutr</infon><infon key="type">ref</infon><infon key="volume">104</infon><infon key="year">2016</infon><offset>36794</offset><text>Vitamin D status is associated with uteroplacental dysfunction indicated by pre-eclampsia and small-for-gestational-age birth in a large prospective pregnancy cohort in Ireland with low vitamin D status</text></passage><passage><infon key="fpage">25</infon><infon key="issue">1â2</infon><infon key="lpage">29</infon><infon key="name_0">surname:Christakos;given-names:S</infon><infon key="name_1">surname:Dhawan;given-names:P</infon><infon key="name_2">surname:Porta;given-names:A</infon><infon key="name_3">surname:Mady;given-names:LJ</infon><infon key="name_4">surname:Seth;given-names:T</infon><infon key="pub-id_doi">10.1016/j.mce.2011.05.038</infon><infon key="pub-id_pmid">21664413</infon><infon key="section_type">REF</infon><infon key="source">Mol Cell Endocrinol</infon><infon key="type">ref</infon><infon key="volume">347</infon><infon key="year">2011</infon><offset>36997</offset><text>Vitamin D and intestinal calcium absorption</text></passage><passage><infon key="fpage">795</infon><infon key="issue">4</infon><infon key="lpage">826</infon><infon key="name_0">surname:Kovacs;given-names:CS</infon><infon key="pub-id_doi">10.1016/j.ecl.2011.08.002</infon><infon key="section_type">REF</infon><infon key="source">Endocrinol Metab Clin N Am</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">2011</infon><offset>37041</offset><text>Calcium and bone metabolism disorders during pregnancy and lactation</text></passage></document></collection>
